why did the fda ban bpc-157 An Committee Just Voted in Favor of Peptides—Despite Agency's Opposition The pro-peptide stacked FDA advisory

Sources: Sikiric et al., Curr Pharm Des 2018 | Chang et al., J Appl Physiol 2011 Security Profile & Chemical Identity Molecular specifications and preclinical safety data BPC-157 Chemical Identity Synthetic pentadecapeptide derived from human gastric juice BPC-157 Tolerance & Status Safety data from preclinical studies (rat, mouse, rabbit, dog) Published Preclinical Data 6 key studies published in J Orthop Res, J Appl Physiol, Curr Pharm Des, Growth Horm IGF Res and Am J Sports Med Biomechanics Significant improvement in tendon strength, stiffness and elasticity modulus at 14 days Achilles tendon repair (rat) Migration Dose-dependent acceleration of tendon fibroblast migration Tendon Repair Mechanisms Cytoprotection Novel cytoprotective mediator vascular recruitment and healing of the gastrointestinal tract Documented Gastroprotective Effects Important Notice Search Only Not intended for human consumption

BPC-157 administration (10 mcg/kg or 10 ng/kg intraperitoneally, or 0.16 mcg/ml in drinking water) produced recovery of esophagitis lesions both macroscopically and microscopically

Lundbeck A/S, and Abbott Canada

Encourages improved sleep, affecting hunger and fat storage hormones

Blood pressure often increases